PROspect Registry :Post Market Clinical Follow-up Study
ConditionBreast Surgery
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorStryker Endoscopy
About this trial
Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)
Eligibility criteria
Qualifiers
Subject was ≥ 18 years of age at the time of the surgery
Patients who have undergone breast surgical procedures using MOLLI, SPY-PHI, and/or SPY AGENT GREEN
Disqualifiers
Subjects who are less than 1-month post-intervention
Concurrent participation in an interventional investigational clinical study at the time of initial surgery
Subjects whose surgery date was prior to January 2022.
Pregnant or lactating females at the time of initial surgery
Trial design
Treatments tested in this trial
- Standard of care treatment
Treatment groups
5,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov